Robert Mousselli
Pain Medicine · Austin, TXNPI 1811309016
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (56.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Medtronic at 49.6% of the total. Reporting peaked in 2023 at $22,163 and has fallen 80.5% since, to $4,328 in 2025. Among pain medicine clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 243 payments — averaging $138.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$17K
- Abbott$9K
- Spinal Simplicity, LLC$3K
- Boston Scientific$2K
- SPR Therapeutics, Inc$649
- Globus Medical$235
- plus $1K from 16 others
What the payments were for
- Grants$19,09157%
- Travel & lodging$5,32016%
- Food & beverage$9,15227%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 97 | $16,660 |
| Abbott | 3 | $9,389 |
| Spinal Simplicity, LLC | 79 | $3,478 |
| Boston Scientific | 11 | $1,904 |
| SPR Therapeutics, Inc | 12 | $649 |
| Globus Medical | 3 | $235 |
| Nevro Corp. | 5 | $223 |
| Saluda Medical Americas, Inc. | 5 | $164 |
| Nalu Medical, Inc. | 3 | $161 |
| AbbVie | 5 | $116 |
| Averitas Pharma Inc. | 4 | $95 |
| Bioventus LLC | 3 | $93 |
| Orthofundamentals, LLC | 1 | $84 |
| Biotronik NRO, Inc. | 2 | $53 |
| Si-bone, Inc. | 2 | $49 |
| Fidia Pharma USA Inc. | 2 | $45 |
| Relievant Medsystems, Inc. | 1 | $40 |
| Vertos Medical, Inc. | 1 | $33 |
| Painteq LLC | 1 | $25 |
| Protega Pharmaceutials Inc | 1 | $24 |
| Ipsen Biopharmaceuticals, Inc | 1 | $23 |
| Azurity Pharmaceuticals, Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMEDII$10,351
- HA MINUTEMAN G3-R$2,471
- INTELLIS ADAPTIVESTIM$2,433
- VANTA ADAPTIVESTIM$811
- VERCISE$613
- LIBERTY SI$453
- INCEPTIV$444
- SPRINT PNS System$269
- Senza$225
- ETERNA$149
- PROCLAIM$148
- Nalu Neurostimulation System$116
- Omnia$106
How this compares
$33,563 in reported general payments places this provider in the 90th percentile of 583 pain medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 18 | $400 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Austin
- Raj PatelAustin$120K
- Ramesh SingaAustin$34K
- Mahan OstadianAustin$27K
- Raimy AmashaAustin$26K
- Matthew McCartyAustin$26K
- Sauman RafiiAustin$24K
- Melissa MurphyGrapevine$653K
- Shiraz YazdaniLubbock$514K
- Aaron CalodneyTyler$296K
- Candice BurnetteSugar Land$265K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.